SLC5A2 and myocardial infarction: Furthermore, various aldosterone receptor antagonists and sodium-glucose cotransporter 2 (SGLT2) inhibitors have been observed to attenuate I/R injury as well as infarct size due to myocardial infarction by multiple mechanisms including inflammation and oxidative stress [104,105].